Clinitech Laboratory Share Price Today | Stock Price & Clinitech Laboratory Share Screener
Track the current Clinitech Laboratory share price and stock price live with TickJournal's free stock screener. Track CTLLAB market cap trends to gauge the company's total market size. Use the Clinitech Laboratory stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Clinitech Laboratory opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Clinitech Laboratory Share Price Chart
Track the current stock price of Clinitech Laboratory with an interactive chart. Analyse CTLLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Clinitech Laboratory stock quote in one place.
Clinitech Laboratory Company Profile - Fundamental Screener
Screen Clinitech Laboratory company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CTLLAB shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE0QMR01015.
Company Details
Classification
Identifiers and Leadership
Clinitech Laboratory Balance Sheet Screener
Screen CTLLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹11, down from ₹11 in 2025.
Latest statistics put total assets at ₹11 and shareholder funds at ₹9, with a leverage ratio of 0.03.
| Item | 2026 | 2025 |
|---|---|---|
Assets |
||
| Total Assets | 11 | 11 |
| Current Assets | 0 | 0 |
| Fixed Assets | 2 | 2 |
Liabilities |
||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 1 | 0 |
| Non-Current Liabilities | 0 | 0 |
Shareholders' Equity |
||
| Total Equity | 9 | 9 |
| Share Capital | 2 | 2 |
| Reserves & Surplus | 7 | 7 |
Clinitech Laboratory Income Statement Screener - Profit & Revenue Analysis
Screen Clinitech Laboratory income statement and profit fundamentals. Analyze CTLLAB quarterly results. Clinitech Laboratory reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹10 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March |
|---|---|---|---|
Revenue and Expenses | |||
| Revenue | 0 | 10 | 9 |
| Expenses | 0 | 9 | 7 |
Operating Costs and Margins | |||
| EBITDA | 0 | 1 | 1 |
| Operating Profit % | 0.00% | 10.00% | 10.00% |
| Depreciation | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 |
Profit and Earnings | |||
| Profit Before Tax | 0 | 1 | 1 |
| Tax | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 |
| EPS | 0.00 | 1.83 | 1.90 |
Clinitech Laboratory Cash Flow Screener - Liquidity Fundamentals
Screen CTLLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹1, and net cash flow was an outflow of ₹1.
Over the same period, investing activities used ₹1 and financing activities provided ₹1.
| Item | 2026-March | 2025-March |
|---|---|---|
Cash from Operations and Investing | ||
| Operating Activities | -1 | -1 |
| Investing Activities | -1 | -1 |
Financing and Net Cash | ||
| Financing Activities | 1 | 4 |
| Net Cash Flow | -1 | 2 |
Clinitech Laboratory Shareholding Pattern Screener
See Clinitech Laboratory shareholding pattern with promoter, FII, and DII holdings. Check Clinitech Laboratory promoter holding and ownership changes for CTLLAB on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 64.20%, foreign institutions 0.32%, domestic institutions 0.00% and the public 34.17%, spread across 297 shareholders.
The shareholder count was 297 in 2026-Mar, compared with 267 in 2026-Sept.
| Item | 2026-Mar | 2026-Sept | 2025-Mar | 2025-Sept | 2024-Jan | 2024-Jul | 2024-Sept |
|---|---|---|---|---|---|---|---|
Promoter Holding | |||||||
| Promoter Holding | 64.20% | 64.63% | 61.58% | 62.42% | 83.63% | 61.58% | 61.58% |
Institutional Investors | |||||||
| FII Holding | 0.32% | 0.32% | 0.32% | 0.32% | 0.00% | 0.32% | 0.32% |
| DII Holding | 0.00% | 0.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | |||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.17% | 32.76% | 36.28% | 35.91% | 0.00% | 33.81% | 35.91% |
| Other Holding | 1.31% | 1.67% | 1.83% | 1.36% | 16.37% | 4.30% | 2.20% |
| Shareholder Count | 297 | 267 | 303 | 303 | 24 | 450 | 346 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Clinitech Laboratory. Clinitech Laboratory dividend yield can be compared with peers and other stocks in the market.
Clinitech Laboratory Stock Index Membership - Nifty & Sensex
See which indices include Clinitech Laboratory stock. Check CTLLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Clinitech Laboratory Market Events Screener - Corporate Actions
Get Clinitech Laboratory corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Clinitech Laboratory stock events that may affect CTLLAB share price, along with derivatives, futures and options activity and sector gainers.
7 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2026, with a record date of November 13, 2026.
It is followed by Annual General Meeting dated September 24, 2026 and Quarterly Result Announcement dated May 28, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-13 | 2026-11-13 | Quarterly Result Announcement | NA | 0.00% |
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | -5.14% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 4.76% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | -14.50% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -1.22% |
Clinitech Laboratory Competitors Screener - Peer Stocks Comparison
Screen CTLLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 125,272 | 53.90 | 25,420 | 15.58% | 2,003 | 61.89 |
| Max Healthcare Institute | 100,339 | 71.20 | 8,536 | 18.82% | 1,442 | 76.17 |
| Manipal Health Enterprises | 92,333 | 104.20 | 10,521 | 25.80% | 917 | 60.80 |
| Aster DM Quality Care | 64,325 | 116.10 | 4,769 | 11.25% | 427 | 57.55 |
| Fortis Healthcare | 60,910 | 57.00 | 9,179 | 16.93% | 1,064 | 57.30 |
| Narayana Hrudayalaya | 38,984 | 45.00 | 7,996 | 43.43% | 811 | 61.49 |
| Global Health | 38,830 | 62.80 | 4,509 | 19.56% | 554 | 64.64 |
| Dr. Lal Path Labs | 33,237 | 57.20 | 2,864 | 12.11% | 510 | 54.28 |
| Krishna Institute of Medical Sciences | 32,269 | 163.00 | 3,931 | 28.16% | 242 | 66.73 |
| Syngene International | 17,533 | 95.70 | 3,809 | 2.56% | 317 | 61.78 |
Clinitech Laboratory Company Announcements - News & Reports Screener
Screen CTLLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 15, 2026.
The next most recent announcements are dated November 15, 2026 and November 15, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-15 | Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations 2015 | - |
| 2026-11-15 | Unaudited Standalone & Consolidated Financial Results For The Half Year Ended September 30 2026 | - |
| 2026-11-15 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E On Friday November 13 2026 At 12.00 Noon (IST) Through Video Conferencing | - |
| 2026-11-06 | Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday November 13 2026 Through Video Conferencing At 12.00 Noon (IST) | - |
| 2026-10-22 | Non-Applicability Of Regulation 23 Of SEBI (LODR) Regulations 2015 W.R.T Related Party Transactions | - |
| 2026-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-26 | Closure of Trading Window | - |
| 2026-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-22 | Annual General Meeting To Be Held On September 24 2026 | - |
| 2026-08-22 | Fixes Book Closure Date For 16Th AGM | - |
| 2026-08-22 | Reg. 34 (1) Annual Report. | - |
| 2026-08-17 | Board Meeting Outcome for Outcome Of Board Meeting Held Today On Monday August 17 2026 At 11.30 A.M (IST) Through Video Conferencing | - |
| 2026-08-12 | Board Meeting Intimation for Board Meeting To Be Held On Monday August 17 2026 Through Video Conferencing At 11.30 A.M (IST). | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-05-28 | Statement Of Deviation & Variation As On March 31 2026 | - |
| 2026-05-28 | Results- Financial Results For Half Year And Financial Year Ended March 31 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Outcome Of Board Meeting Held For FY 2026-27 Today I.E May 28 2026 Through Video Conferencing At 02.30 P.M | - |
| 2026-05-22 | Board Meeting Intimation for Board Meeting For FY 2026-27 To Be Held On Thrusday May 28 2026 At 02.30 P.M Through Video Conferencing | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 0.74. Market capitalisation stands at ₹6.80 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on November 19, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.